New whitepaper: Powered by Partnership & Patient Experience
Pharma has long been guilty of putting profit before people, but that's beginning to change. While there's still a long road ahead, patient-engagement efforts are steadily improving.

This is being shared with you as part of the exciting buildup to this year’s Pharma & Patient USA 2024 (Oct 15-16, Boston) conference, where patient champions will gather to incorporate the patient voice at all stages.
The report delves into many important key areas, including:
  • Measuring impact and demonstrating value: Pharma are pulling back on funding for advocacy groups due to lack of demonstrable ROI. How can pharma extrapolate the right metrics and measure true ROI in patient engagement?
  • Closing the gap on access: What partnerships are required to increase engagement within minority communities, such as the LGBTQIA+ space, to ensure diverse representation in pharma clinical trials?
  • Brave new frontiers of technology and patient experience: Generate insights and patterns in patient data to deliver more personalized treatments and improved outcomes.
Provided to you ahead of Pharma & Patient USA 2024, our stellar speaker line-up includes: 
We hope you enjoy!

Kindest regards,
Gain exclusive access to Powered by Partnership & Patient Experience 

Fill out the form below to access your white paper: 
Reuters Events will use this information to contact you about relevant content, products, and services. You may unsubscribe at any time. For more information, check out our Privacy Policy: https://www.thomsonreuters.com/en/privacy-statement.html.
Jacob Byerley
Conference Producer | Pharma & Patient USA 2024
Pharma
Reuters Events

Reuters Events is part of Reuters News & Media Ltd, 5 Canada Square, Canary Wharf, London, E14 5AQ. Registered in England and Wales: 2505735.